IL6 and hepatocellular carcinoma: One study demonstrated that IL-17 has a direct effect over HCC with the induction of IL-6/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) by activating the protein kinase B (AKT) pathway.48